Role of risk stratification after myocardial infarction

Current Treatment Options in Cardiovascular Medicine

Volumn 11, Issue 1, 2009, Pages 10-21

  Kuriachan, Vikas ^a   Exner, Derek V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHENYLEPHRINE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HEART REPOLARIZATION; HIGH RISK PATIENT; HUMAN; INVASIVE PROCEDURE; NEUROMODULATION; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRESSORECEPTOR REFLEX; PUBLIC HEALTH PROBLEM; QT INTERVAL; RISK ASSESSMENT; RISK MANAGEMENT; SUDDEN DEATH; T WAVE INVERSION;

EID: 58649094435     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-009-0002-z     Document Type: Article

References (49)

1. Myerburg RJ: SudEen cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001, 12: 369-381.
2. Rea TD, Pearce RM, Raghunathan TE, et al.: Incidence of out-of-hospital cardiac arrest. Am J Cardiol 2004, 93: 1455-1460.
3. Epstein AE, DiMarco JP, Ellenbogen KA, et al.: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51: E1-e62.
4. National Heart, Lung, and Blood Institute: Morbidity and Mortality: 2007 Chartbook on Cardiovascular, Lung, and Blood Diseases. Available at http://www.nhlbi.nih.gov/resources/docs/cht-book.htm. Accessed October 2008.
5. Ezekowitz JA,IRowe BH, Dryden DM, et al.: Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007, 147: 251-262.
6. Bauer A, Kantelhardt JW, Barthel P, et al.: Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 2006, 367: 1674-1681.
7. Makikallio TH, Barthel P, Schneider R, et al.: Prediction of sudden cardiac death after acute myocardial infarction: Role of Holter monitoring in the modern treatment era. Eur Heart J 2005, 26: 762-769.
8. Exner DV, Kavanagh KM, Slawnych MP, et al.: Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007, 50: 2275-2284.
9. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346: 877-883.
10. Kadish A, Dyer A, Daubert JP, et al.: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350: 2151-2158.
11. Bardy GH, Lee KL, Mark DB, et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352: 225-237.
12. Ellenbogen KA, Levine JH, Berger RD, et al.: Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006, 113: 776-782.
13. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335: 1933-1940.
14. La Rovere MT, Bigger JT Jr, Marcus FI, et al.: Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351: 478-484.
15. De Ferrari GM, Sanzo A, Bertoletti A, et al.: Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007, 50: 2285-2290.
16. Nolan J, Batin PD, Andrews R, et al.: Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998, 98: 1510-1516.
17. Hohnloser SH, Kuck KH, Dorian P, et al.: Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351: 2481-2488.
18. Huikuri HV, Makikallio TH, Peng CK, et al.: Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000, 101: 47-53.
19. Schmidt G, Malik M, Barthel P, et al.: Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999, 353: 1390-1396.
20. Cygankiewicz I, Zareba W, Vazquez R, et al.: Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 2008, 5: 1095-1102.
21. Bauer A, Guzik P, Barthel P, et al.: Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 2005, 26: 755-761.
22. Barthel P, Schneider R, Bauer A, et al.: Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003, 108: 1221-1226.
23. Steinberg JS, Regan A, Sciacca RR, et al.: Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 1992, 69: 13-21.
24. Bigger JT Jr: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997, 337: 1569-1575.
25. Malik M, Batchvarov VN: Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000, 36: 1749-1766.
26. Surawicz B: Will QT dispersion play a role in clinical decision-making? J Cardiovasc Electrophysiol 1996, 7: 777-784.
27. Atiga WL, Calkins H, Lawrence JH, et al.: Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998, 9: 899-908.
28. Couderc JP, Zareba W, McNitt S, et al.: Repolarization variability in the risk stratification of MADIT II patients. Europace 2007, 9: 717-723.
29. Jensen BT, Abildstrom SZ, Larroude CE, et al.: QT dynamics in risk stratification after myocardial infarction. Heart Rhythm 2005, 2: 357-364.
30. Chevalier P, Burri H, Adeleine P, et al.: QT dynamicity and sudden death after myocardial infarction: Results of a longterm follow-up study. J Cardiovasc Electrophysiol 2003, 14: 227-233.
31. Cygankiewicz I, Zareba W, Vazquez R, et al.: Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure. J Cardiovasc Electrophysiol 2008, 19: 1-7.
32. Pastore JM, Rosenbaum DS: Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res 2000, 87: 1157-1163.
33. Bloomfield DM, Bigger JT, Steinman RC, et al.: Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006, 47: 456-463.
34. Nearing BD, Verrier RL: Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 2002, 92: 541-549.
35. Ikeda T, Yoshino H, Sugi K, et al.: Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: Results of a collaborative cohort study. J Am Coll Cardiol 2006, 48: 2268-2274.
36. Nieminen T, Lehtimaki T, Viik J, et al.: T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 2007, 28: 2332-2337.
37. Myles RC, Jackson CE, Tsorlalis I, et al.: Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation 2007, 116: 2984-2991.
38. Chow T, Kereiakes DJ, Onufer J, et al.: Stratification of Post MI Patients (MASTER I) Trial. Circulation 2007, 116: 2631.
39. Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114: 32-39.
40. Schmidt A, Azevedo CF, Cheng A, et al.: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115: 2006-2014.
41. Wu KC, Weiss RG, Thiemann DR, et al.: Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51: 2414-2421.
42. Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999, 99: 1978-1983.
43. Dekker LR, Bezzina CR, Henriques JP, et al.: Familial sudden death is an important risk factor for primary ventricular fibrillation: A case-control study in acute myocardial infarction patients. Circulation 2006, 114: 1140-1145.
44. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV: Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 2006, 114: 1462-1467.
45. Daubert JP, Zareba W, Hall WJ, et al.: Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006, 47: 98-107.
46. Redwood SR, Odemuyiwa O, Hnatkova K, et al.: Selection of dichotomy limits for multifactorial prediction of arrhythmic events and mortality in survivors of acute myocardial infarction. Eur Heart J 1997, 18: 1278-1287.
47. Farrell TG, Bashir Y, Cripps T, et al.: Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991, 18: 687-697.
48. Reinhardt L, Makijarvi M, Fetsch T, et al.: Noninvasive risk modeling after myocardial infarction. Am J Cardiol 1996, 78: 627-632.
49. Gold MR, Bloomfield DM, Anderson KP, et al.: A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000, 36: 2247-2253.